Draegerwerk AG & Co. KGaA · XETR:DRW8

Draegerwerk AG & Co. KGaA — Drägerwerk AG & Co. KGaA — H1 2015 Earnings Presentation

18 slides from Draegerwerk AG & Co. KGaA's earnings presentation, Jul 30, 2015

  1. Slide 1: Conference call Interim report January 1 to June 30, 2015

    Conference call Interim report January 1 to June 30, 2015 Lübeck, July 30, 2015

  2. Slide 2: Disclaimer

    Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d

  3. Slide 3: Business development Group

    Business development Group Net Sales Order entry Q2 +10.3% (cc +4.4%) +6.8% +3.4% H1 +11.6% (cc +5.2%) Currency Currency 1.179,5 Book to bill 1.06 (py 1.04) adjusted adjusted 6M Net sales Net of 634,0 Change currency 1.073,2 in € million in % effects in % 559,9 Europe +9.6 +8.6 Americas +11.4 - 3.3

  4. Slide 4: Functional Expenses

    Functional Expenses Change 6M 2014 6M 2015 Change FX adj. € million € million % % R&D -103.6 -114.8 10.8 4.6 % of Net Sales -9.7% -9.7% Sales & Marketing -262.7 -293.1 11.6 4.2 % of Net Sales -24.5% -24.8% Administration -90.0 -107.3 19.2 14.9 % of Net Sales -8.4% -9.1% SG&A -352.8 -400.4 13.5 6.9 %

  5. Slide 5: Medical division: order entry in Q2 2015 and H1 2015

    Business development Medical division: order entry in Q2 2015 and H1 2015 % nom % cc % nom % cc 411.9 +11.3% +5.3% 814.5 +13.2% +6.5% Middle East, +42.7% +32.0% 52.0 +83.9% +72.1% 94.7 Africa & Others +17.7% +2.6% +14.9% +0.2% 69.5 143.1 Asia/Pacific +8.5% -3.3% +15.6% +2.2% 85.0 165.1 Americas +0.5

  6. Slide 6: Business development Medical division

    Business development Medical division Net Sales Order entry +7.4% +3.9% Q2 +11,3% (cc +5.3%) Currency Currency H1 +13,2% (cc +6.5%) adjusted adjusted 760,2 Book to bill 1.07 (py 1.05) 684,4 Q2 with good demand for 405,8 anesthesia, ventilation and 354,3 monitoring. 6M Net sales Net of Q2‘14 Q2‘15 H1

  7. Slide 7: Safety division: order entry in Q2 2015 and H1 2015

    Business development Safety division: order entry in Q2 2015 and H1 2015 % nom % cc % nom % cc 222.1 434.9 +8.7% +3.1% Middle East, +8.5% +2.8% Africa & Others 15.2 +12.1% +3.4% 26.1 +10.6% +2.6% +20.4% +7.2% 67.8 +13.8% +1.2% 37.3 Asia/Pacific +13.7% -1.4% +11.2% -3.9% 37.8 74.0 Americas +3.9% +2.7

  8. Slide 8: Business development Safety division

    Business development Safety division Net Sales Order entry Q2 +8,5% (cc +2.8%) +5.8% +2.4% H1 +8,7% (cc +3.1%) Currency Currency Book to bill 1.04 (py 1.03) adjusted adjusted 419,4 Q2 with good demand for fire fighting and government 388,8 applications. 228,2 205,6 6M Net sales Net of Change currenc

  9. Slide 9: Key Figures

    Key Figures 6M 2014 6M 2015 Change € million € million % Cashflow from operating activities 26.5 -66.5 -350.9 Investments 46.9 121.7 159.5 1 Cash and cash equivalents 178.1 132.1 -25.8 1 Net financial debt 135.7 189.9 39.9 1 2 0.6 0.8 Net financial debt /EBITDA 1 Capital employed 1,081.9 1,310.0 21.

  10. Slide 10: Outlook

    Outlook 2014 2015e Mid term 2019e Net Sales + 4.0% 2.0% – 5.0% 3.0% – 6.0% (net of currency effects) (net of currency effects) (net of currency effects) EBIT margin 7.3% 5.0% – 7.0%* >10 %* Gross margin 46.7% below prior year Operating 105.0% > 50.0% cash flow of EBIT of EBIT Equity ratio 40.1% > 40

  11. Slide 11: Questions & Answers

    Questions & Answers Drager ee “e 1 Drager. Technik fiir das Leben®

  12. Slide 12: Appendix

    Appendix Drager 12

  13. Slide 13: Dräger Group

    Business development Dräger Group Q2 2014 Q2 2015 Change 6M 2014 6M 2015 Change € million € million % € million € million % Order Intake 574.8 634.0 10.3 1 1,119.4 1,249.3 11.6 1 Net Sales 559.9 634.0 13.2 1 1,073.2 1,179.5 9.9 1 % growth 2.3% 13.2% -3.5% 9.9% % growth (currency adjusted) 1.5% 6.8%

  14. Slide 14: Medical and Safety division

    Business development Medical and Safety division Medical Division Q2 2014 Q2 2015 Change 6M 2014 6M 2015 Change € million € million % € million € million % Order Intake 370.2 411.9 11.3 1 719.4 814.5 13.2 1 Net Sales 354.3 405.8 14.5 1 684.4 760.2 11.1 1 EBIT 5.9 11.2 88.7 9.5 15.0 57.0 EBIT Margin

  15. Slide 15: Functional Expenses

    Functional Expenses Q2 2014 Q2 2015 Change 6M 2014 6M 2015 Change € million € million % € million € million % R&D -53.3 -58.5 9.8 -103.6 -114.8 10.8 % of Net Sales -9.5% -9.2% -9.7% -9.7% SG&A -181.5 -203.8 12.3 -352.8 -400.4 13.5 % of Net Sales -32.4% -32.1% -32.9% -33.9% Functional Expenses total

  16. Slide 16: Cash-flow statement

    Cash-flow statement 6M 2014 6M 2015 Change € million € million % Group net profit 14.9 7.7 -47.9 Change in inventories -33.1 -60.9 -83.9 Change in accounts receivables 102.2 45.7 -55.3 Change in accounts payables -34.6 -35.6 -3.0 Depreciation and amortization 35.0 40.0 14.4 Other operating cash flow

  17. Slide 17: Financial calendar

    Financial calendar March 11, 2015 - Accounts press conference, Lübeck - Analysts meeting, Frankfurt April 29, 2015 - Report for the first three months 2015 - Conference call, Lübeck April 30, 2015 - Annual shareholders' meeting, Lübeck July 30, 2015 - Report for the first six months 2015 - Conferenc

  18. Slide 18: Contact

    Contact Melanie Kamann Thomas Fischler Corporate Communications Investor Relations Drägerwerk AG & Co. KGaA Drägerwerk AG & Co. KGaA Moislinger Allee 53−55 Moislinger Allee 53−55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel +49 451 882-3998 Tel +49 451 882-2685 Fax +49 451 882-3944 Fax +49 451 88

Drägerwerk AG & Co. KGaA — H1 2015 Earnings Presentation on 6ix